These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1665406)

  • 1. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
    Müller R; Steffen HM; Brunner R; Saric J; Pollok M; Baldamus CA; Kaufmann W
    Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M; Umezu M; Nagano M; Tagawa H
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.
    Schwartz AB; Prior JE; Mintz GS; Kim KE; Kahn SB
    Transplant Proc; 1991 Apr; 23(2):1827-30. PubMed ID: 2053168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human erythropoietin on adrenergic activity in normotensive hemodialysis patients.
    Ksiazek A; Zaluska WT; Ksiazek P
    Clin Nephrol; 2001 Aug; 56(2):104-10. PubMed ID: 11522086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of blood pressure changes during recombinant human erythropoietin therapy.
    Levin N
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disordered alpha 2-adrenoreceptor function in hemodialysis patients with renal anemia--a possible cause of increased blood pressure in relation to recombinant human erythropoietin?].
    Müller R; Steffen HM; Brunner R; Pollok M; Baldamus CA; Kaufmann W
    Klin Wochenschr; 1991 Oct; 69(16):742-8. PubMed ID: 1662322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Status epilepticus in chronically dialyzed patients treated with erythropoietin].
    Massetani R; Galli R; Calabrese R; Sartucci F; Rindi P; Severino Brandi L; Murri L
    Riv Neurol; 1991; 61(6):215-8. PubMed ID: 1813973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients.
    Huraib S; al-Momen AK; Gader AM; Mitwalli A; Sulimani F; Abu-Aisha H
    Clin Nephrol; 1991 Nov; 36(5):252-7. PubMed ID: 1752076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
    Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
    Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric uses of recombinant human erythropoietin: the outlook in 1991.
    Alexander SR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):42-53. PubMed ID: 1928079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of anemia correction by recombinant human erythropoietin in predialysis patients with renal failure.
    Sapojnikov M; Veksler A; Yagil Y; Kogan J; Turkot S; Boris G; Oren S
    Ren Fail; 2005; 27(2):199-203. PubMed ID: 15807186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Martins Prata M; Teixeira de Sousa F; Barbas J; Vinhaś J; Marques da Costa A
    Rev Port Cardiol; 1990 Feb; 9(2):119-23. PubMed ID: 2346662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of recombinant human erythropoietin [rHuEpo] in man.
    Adamson JW; Eschbach JW
    Prog Clin Biol Res; 1990; 352():505-17. PubMed ID: 2205875
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of erythropoietin therapy on alpha receptor density in chronic dialysis patients].
    Fritschka E; Neumayer HH; Seddighi S; Distler A; Philipp T
    Med Klin (Munich); 1991 Jul; 86(7):353-9. PubMed ID: 1656181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients?
    de Fijter CW; Popp-Snijders C; Oe LP; Tran DD; van der Meulen J; Donker AJ
    Haematologica; 1995; 80(4):332-4. PubMed ID: 7590502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effects of recombinant human erythropoietin on the cardiovascular system.
    Eschbach JW; Aquiling T; Haley NR; Fan MH; Blagg CR
    Clin Nephrol; 1992; 38 Suppl 1():S98-103. PubMed ID: 1295715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.